Stay updated on Ponatinib, Mini-hyper CVD, Venetoclax in T-ALL Clinical Trial
Sign up to get notified when there's something new on the Ponatinib, Mini-hyper CVD, Venetoclax in T-ALL Clinical Trial page.

Latest updates to the Ponatinib, Mini-hyper CVD, Venetoclax in T-ALL Clinical Trial page
- Check7 days agoChange DetectedRecruitment status changed to 'No longer looking for participants,' indicating enrollment has ended. The page history also notes a new release version, v3.6.0.SummaryDifference0.5%

- Check14 days agoChange DetectedNew revision entry v3.5.5 appears in the history. The previous revision v3.5.4 is removed from the history list.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check36 days agoChange DetectedRevision label updated to v3.5.4, indicating a new site release. This reflects a platform/UI update rather than changes to study data or page content.SummaryDifference0.1%

- Check50 days agoChange DetectedThe history now marks the study as Terminated with < 75% participation, replacing the previous Active, not recruiting status, with a last update date of 2026-04-27; the history also introduces new sections and a new revision (v3.5.3) in the record.SummaryDifference0.9%

- Check64 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check93 days agoChange DetectedRevision v3.5.0 was added to the history and revision v3.4.3 was removed.SummaryDifference0.2%

Stay in the know with updates to Ponatinib, Mini-hyper CVD, Venetoclax in T-ALL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ponatinib, Mini-hyper CVD, Venetoclax in T-ALL Clinical Trial page.